Pylarify injections
Ended Awarded Last action
- Contract number
- 36C24623N0878
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $855,267
Award facts
- Opportunity
-
- 36C24623Q0930 Solicitation number
- Contract value 100% obligated
- $855,266.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$227,349 | |
| Original award | $1,082,616 |
About this award
This federal contract award, valued at $855,266.64, was issued by the Department of Veterans Affairs (VA) to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc. The contract is for the delivery of PYLARIFY (piflufolastat F-18) injections, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer.
The contract is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, with a firm-fixed-price pricing type and a period of performance through December 2024. While the contract is not set aside, Progenics Pharmaceuticals has received both set-aside and unrestricted awards from the VA, Department of Defense, and National Institutes of Health for the supply of PYLARIFY and other radiopharmaceuticals to support federal healthcare programs. The company holds several Blanket Purchase Agreements (BPAs) with the VA and Defense Health Agency to facilitate the ongoing procurement of these critical diagnostic agents.
Quick answers
Who was awarded contract 36C24623N0878?
36C24623N0878 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on July 24, 2023.
How much is contract 36C24623N0878 worth?
The government has obligated $855,267 on 36C24623N0878.
Is contract 36C24623N0878 an order under another contract?
Yes. 36C24623N0878 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24623N0878 competed?
The extent of competition for 36C24623N0878 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award